Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions.
Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck.
With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck’s expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.
|ClearDATA Networks||12/2013||Series B||$7M||1|
|GenomeDx Biosciences||9/2013||Series B||4|
|PatientSafe Solutions||9/2013||Series C||$7M||4|
|eHealth Technologies||1/2013||Series D||1|
|PatientSafe Solutions||1/2013||Series C||$20M||3|
|Remedy Informatics||11/2012||Venture Round||$6M||1|
|Liaison Technologies||4/2012||Series A||$30M||1|
|Physicians Interactive||1/2012||Venture Round||$17M||1|
|Daktari Diagnostics||12/2011||Venture Round||$10M||3|